COVID-19 Vaccine: Booster Dose | Pantai Hospitals - Pantai Malaysia
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect
COVID-19 vaccine breakthrough infections | Science
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Boosting immunity to COVID-19 vaccines | Nature Medicine
Measuring Vaccination Impact & Coverage
BioNTech SE on X: "95.6% relative vaccine efficacy against #Covid19 after a booster shot with our #mRNA vaccine, during a period when Delta was the prevalent strain. These are the first efficacy
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
COVID-19 Vaccines and Booster Shots: Which Combination is Most Effective? - Homage Malaysia
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas
Pfizer/BioNTech COVID-19 booster dose demonstrates high efficacy
Covid booster vaccines effective against severe illness from omicron, CDC says
Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations
Testing fractional doses of COVID-19 vaccines | PNAS
